2018 Stanford Drug Discovery Conference

Date: April 23, 2018 @ 9:00 am – April 24, 2018 @ 5:00 pm
Location: Li Ka Shing Conference Center

2018 Stanford Drug Discovery Conference

April 23-24, 2018
Li Ka Shing Conference Center

| Register Here |

| Shark Tank Application |

Now accepting applications for translational stage projects to be presented to a panel of leading scientists, CEOs, and entrepreneurs.

This is a great way to showcase your company, receive informal feedback from industry experts, and network with industry/academia/VC leaders. There is no financial obligation or guarantee of investment. There will be a non-monetary prize for best product/business plan.

The Shark Tank panel includes Roy Vagelos, MD; George Scangos, PhD; Ram Shriram; Robert Robbins, MD; and Amy Chang


Day 1 | April 23, 2018

Welcoming Remarks and Introduction

Joseph Wu, MD, PhD | Director, Stanford Cardiovascular Institute

Lloyd Minor, MD | Dean, Stanford School of Medicine

David Entwistle | CEO, Stanford Health Care

Dennis Lund, MD | Chief Medical Officer, Lucille Packard Children’s Hospital Stanford

Opening Keynote

Brian Kobilka, MD | "Structure-based Approaches for G Protein Coupled Receptor Drug Discovery"

Q & A Session

Academic Drug Discovery Process

Session Chairs and Moderators: Janet Woodcock, MD, and Joseph Wu, MD, PhD

Kathleen Giacomini, PhD

Kevan Shokat, PhD | "Chemical Tricks for Drugging the Undruggable"

Hugh Rosen, MD, PhD | "Intelligent Intervention: Ozanimod from Hit to NCE at Scripps"

Edgar Engleman, MD | "Treating Disease by Manipulating the Immune System"

Panel Discussion

View From the Top

Ken Frazier | "Inventing for Life: the CEO Perspective"

Joe Jimenez | "Outcomes Based Pricing"

Patrick Soon-Shiong, MD | "Patient as the Biological Factory of the Future"

Bob Bradway | "Moving from 'Break/Fix' to 'Predict/Prevent'"

Brent Saunders | "Using the Innovation Ecosystem to Build a Robust Pipeline"

Sanford Weill | "Philanthropy's Vital Role in Partnering with Healthcare"

Panel Discussion

Fireside Chat

Marc Tessier-Lavigne, FRS, FRSC, FMedSci

Lloyd Minor, MD

Q & A Session

Presentation of Lifetime Achievement Award to Roy Vagelos, MD

Introduction: Paul Berg, PhD, and Ken Frazier

Awardee Lecture: Roy Vagelos, MD | "A Career in Drug Discovery"

Day 2 | April 24, 2018

Keynote Address

Kuldev Singh, MD | Introduction

Janet Woodcock, MD | "Changes on the Horizon for the New Drug Regulatory Program"

Q & A Session

Publishing Drug Discovery

Session Chair and Moderator: Sanjay Malhotra, PhD

Howard Bauchner, MD | "Evolving Issues in Medical Journalism"

John Keaney, MD | "Editorial Considerations in the Evaluation of New Therapies"

Paula Kiberstis, PhD | "Drug Discovery and Science: What's behind the Curtain?"

Joao Monteiro, MD, PhD | "Transparency and Reproducibility in Science: How Journals Can Help"

Round Table Discussion

Funding Agency Perspectives

Session Chair and Moderator: Joseph Wu, MD, PhD

Gary Gibbons, MD | "Charting Our Future Together: Advancing Discovery Science for Public Health Impact"

Maria Millan, MD

Q & A Session

Starting Up

George Scangos, PhD | "Transitioning from Big Pharma to Startup"

Shark Tank-style Panel featuring:

Roy Vagelos, MD
George Scangos, PhD
Ram Shriram
Robert Robbins, MD
Amy Chang
Wende Hutton

Closing Remarks / Poster Prize Award Announcement

RSVP – $0 (USD)